Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment
Alterfines / Pixabay

Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment

Dr. David Pisetsky, a translational researcher at the Medical Center of Duke University, recently described his team’s new approach to treating potential Lupus patients. The doctor told the Rheumatologist of…

Continue Reading Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment
This Organization is Offering Spinal Muscular Atrophy Patients Financial Aid for Treatment
source: pixabay.com

This Organization is Offering Spinal Muscular Atrophy Patients Financial Aid for Treatment

According to a story from SMA News Today, the Patient Access Network (PAN) Foundation announced that it is now offering financial assistance to help patients living with the rare disease…

Continue Reading This Organization is Offering Spinal Muscular Atrophy Patients Financial Aid for Treatment
Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
source: pixabay.com

Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse

In a recent study published in Clinical and Experimental Immunology, researchers determined that patients with high ANCA antibody levels are at an increased risk of having ANCA-associated vasculitis (AAV) relapses. According…

Continue Reading Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
A New Investigative Treatment Option for Acute Myeloid Leukemia Produces Positive Results
source: pixabay.com

A New Investigative Treatment Option for Acute Myeloid Leukemia Produces Positive Results

A new study has uncovered that using a hypomethylating agent in combination with a BCL2 inhibitor called Venetoclax may be advantageous as a therapeutic option for individuals with acute myeloid…

Continue Reading A New Investigative Treatment Option for Acute Myeloid Leukemia Produces Positive Results

New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies

Researchers at the Mayo Clinic have collaborated with the international community to develop a potential way to test for spinocerebellar ataxia type 3 (SCA3), also called Machado-Joseph Disease. Additionally, they…

Continue Reading New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies

Study Reinforces the Importance of Vaccines for Congenital Lactic Acidosis Patients and Other Rare Diseases

A recent study published in PLOS ONE has reinforced the importance of vaccinations specifically for those already fighting a rare disease. This study was written by Sylvie Lesage from the…

Continue Reading Study Reinforces the Importance of Vaccines for Congenital Lactic Acidosis Patients and Other Rare Diseases